Bharat Immunologicals P/E Ratio
Bharat Immunologicals (BIBCL) P/E ratio is not applicable — EPS (TTM) ₹-3.95. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
No recent earnings data available.
Current EPS: ₹-3.95
Healthcare Peers with Valid P/E Ratios — BIBCL Comparison
Healthcare sector average P/E 49.05, median 29.34 — BIBCL excluded (negative EPS).
Sector Average PE
49.05
Sector Median PE
29.34
Lowest PE
0.97
Profitable Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see BIBCL share price screener.
- Browse BIBCL cash flow statement for revenue, profit, balance sheet and cash flow data.
- Analyse Bharat Immunologicals ownership pattern to track promoter, FII and institutional holdings.